Skip to main content
ConductScienceScienceDex

Kapil Bhalla

NIH Rank #9308
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1863849Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2025 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$1.4M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#9,308
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Kapil Bhalla. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Kapil Bhalla as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA262636-04R01
    Novel combination therapy for AML expressing mutant RUNX1
    UT MD Anderson Cancer Center
    $507.5K
    award amount
  • 5R01CA255721-04R01
    Biology and novel therapy of AML expressing somatic or germline mutant RUNX1
    UT MD Anderson Cancer Center
    $472.1K
    award amount
  • 5R01CA233457-05R01
    Targeting dysregulated transcriptome as therapy for post-myeloproliferative neoplasm (MPN) sAML
    UT MD Anderson Cancer Center
    $452.1K
    award amount

Award organization

Organizations that administered FY2024 awards listing Kapil Bhalla as a PI.

FY2024 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #9308
  5. 2024
    R01 Grant Holder
  6. 2025
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Kapil Bhalla.

Courtney Dinardo
UT MD Anderson Cancer Center
4
shared awards
Warren Campbell Fiskus
UT MD Anderson Cancer Center
3
shared awards
Koichi Takahashi
UT MD Anderson Cancer Center
1
shared award
Srdan Verstovsek
UT MD Anderson Cancer Center
1
shared award

Explore further

Find collaborators for Kapil Bhalla

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →